By Ambar Bhattacharyya
We are proud to announce our continued investment in Centivo, and we are pleased to be one of the lead investors in their most recent $51M funding round, co-leading with B Capital Group.
Centivo has experienced rapid growth and expansion since implementing its first client in 2019. During the first nine months of 2021, Centivo significantly expanded its market presence to key MSAs in New York, New Jersey, Connecticut, Iowa, Pennsylvania and Wisconsin (joining central Florida, North Carolina, Southern California and Nebraska.) It also recently developed new strategic distribution arrangements with BHCG in eastern Wisconsin.
Self-funded employers and their employees are facing a true healthcare affordability crisis, while rising premiums, surprise bills, and the lack of transparency in our complex healthcare system is leading to low-quality primary care. By providing data-driven tools to recommend the most appropriate and affordable care, Centivo lowers healthcare spend for employers, and offers employees and their families the high-quality healthcare they need. We believe Centivo is primed to be a leading driver of change for the better.
Since first investing in the company back in April 2018, we’ve seen firsthand the tremendous growth they’ve experienced, as well as their profound mission to make healthcare effective and affordable. Congratulations again to Ashok and the entire Centivo team and we look forward to the continued success ahead.
The views expressed herein are solely the views of the author(s) and are not necessarily the views of Maverick Capital, Ltd. or any of its affiliates. They are not intended to provide, and should not be relied upon for, investment advice.